Xu Lei, Zhang Tao, Zhu Baojie, Tao Honglin, Liu Yue, Liu Xianfeng, Zhang Yi, Meng Xianli
State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
J Pharm Anal. 2025 Apr;15(4):101146. doi: 10.1016/j.jpha.2024.101146. Epub 2024 Nov 14.
Neurodegenerative disorders (NDDs) are prevalent chronic conditions characterized by progressive synaptic loss and pathological protein alterations. Increasing evidence suggested that mitochondrial quality control (MQC) serves as the key cellular process responsible for clearing misfolded proteins and impaired mitochondria. Herein, we provided a comprehensive analysis of the mechanisms through which MQC mediates the onset and progression of NDDs, emphasizing mitochondrial dynamic stability, the clearance of damaged mitochondria, and the generation of new mitochondria. In addition, traditional Chinese medicines (TCMs) and their active monomers targeting MQC in NDD treatment have been demonstrated. Consequently, we compiled the TCMs that show great potential in the treatment of NDDs by targeting MQC, aiming to offer novel insights and a scientific foundation for the use of MQC stabilizers in NDD prevention and treatment.
神经退行性疾病(NDDs)是常见的慢性疾病,其特征是进行性突触丧失和病理性蛋白质改变。越来越多的证据表明,线粒体质量控制(MQC)是负责清除错误折叠蛋白质和受损线粒体的关键细胞过程。在此,我们全面分析了MQC介导NDDs发生和发展的机制,重点关注线粒体动态稳定性、受损线粒体的清除以及新线粒体的生成。此外,已经证明了中药及其活性单体在NDD治疗中靶向MQC的作用。因此,我们汇编了通过靶向MQC在NDD治疗中显示出巨大潜力的中药,旨在为MQC稳定剂在NDD预防和治疗中的应用提供新的见解和科学依据。
Antioxidants (Basel). 2020-10-28
Neurochem Res. 2019-8-13
J Cell Mol Med. 2022-2
Neurobiol Dis. 2021-5
Antioxid Redox Signal. 2015-4-20
Int J Mol Sci. 2024-1-12